The SBD documents explain why Health Canada authorized certain medical devices for sale in Canada. The documents include regulatory, safety, effectiveness and quality (manufacturing) considerations.
SBDs are published for a subset of Class IV medical device applications that were authorized after January 1, 2005. Health Canada will draft Phase II SBDs for all eligible medical devices licensed as of September 1, 2012. Eligible products authorized before September 1, 2012, but on or after January 1, 2005, will have SBDs in the Phase I format.
The SBDs are organized alphabetically by product name. Use the following index, or see the list of SBDs below.
For an explanation of the information available in each section of a Phase I SBD, consult the Phase I Reader's Guide.
For an explanation of the information available in each section of a Phase II SBD, consult the Phase II Reader's Guide.
For up to date information on a particular product, readers should refer to the Medical Devices Active Licence Listing.
For information related to Warnings, Recalls and Alerts, go to the MedEffect Canada web page.
Readers should refer to the
Food and Drugs Act and/or the
Medical Devices Regulations for more information about the regulation of medical devices.
Readers may also wish to consult the Health Canada website for other policies and guidance documents related to medical devices and medical device applications. In particular, readers may wish to refer to the Management of Applications for Medical Device Licences and Investigational Testing Authorizations Policy.
Summary Basis of Decision Documents: Medical Devices